These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 32920632)
1. The Role of Clinical Trials in Preclinical Alzheimer's Disease Drug Development Programs. Cummings J J Prev Alzheimers Dis; 2020; 7(4):288-290. PubMed ID: 32920632 [No Abstract] [Full Text] [Related]
2. Editorial: The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) - A Fundamental Ally in AD Prevention Research. Porsteinsson AP; Clark ED J Prev Alzheimers Dis; 2020; 7(4):206-207. PubMed ID: 32920620 [No Abstract] [Full Text] [Related]
3. The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview. Aisen PS; Sperling RA; Cummings J; Donohue MC; Langford O; Jimenez-Maggiora GA; Rissman RA; Rafii MS; Walter S; Clanton T; Raman R J Prev Alzheimers Dis; 2020; 7(4):208-212. PubMed ID: 32920621 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction: A potential target for Alzheimer's disease intervention and treatment. Ke J; Tian Q; Xu Q; Fu Z; Fu Q Drug Discov Today; 2021 Aug; 26(8):1991-2002. PubMed ID: 33962036 [TBL] [Abstract][Full Text] [Related]
6. Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials. Hung A; Schneider M; Lopez MH; McClellan M J Manag Care Spec Pharm; 2020 Jul; 26(7):888-900. PubMed ID: 32584672 [TBL] [Abstract][Full Text] [Related]
11. A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group. O'Gorman C; Khoury R; Anderson A; Carter M; DiCesare F; Dubé S; Ereshefsky L; Grossberg G; Hefting N; Khan S; Lind S; Moebius H; Shiovitz T; Rosenberg P J Prev Alzheimers Dis; 2020; 7(4):274-282. PubMed ID: 32920630 [No Abstract] [Full Text] [Related]
12. Be open about drug failures to speed up research. Alteri E; Guizzaro L Nature; 2018 Nov; 563(7731):317-319. PubMed ID: 30425369 [No Abstract] [Full Text] [Related]
13. Editorial: Accelerating Preclinical Alzheimer's Clinical Trials through a Trial-Ready Cohort with Diverse Representation. Lee AKW; Correia S; Salloway SP J Prev Alzheimers Dis; 2020; 7(4):204-205. PubMed ID: 32920619 [No Abstract] [Full Text] [Related]
14. New Approaches to Develop Drug Treatment for Alzheimer's Disease: Targeting Calcium Dysregulation. Wei H Curr Alzheimer Res; 2020; 17(4):311-312. PubMed ID: 32623998 [No Abstract] [Full Text] [Related]
15. Alzheimer's disease: future drug development and the blood-brain barrier. Pardridge WM Expert Opin Investig Drugs; 2019 Jul; 28(7):569-572. PubMed ID: 31155971 [No Abstract] [Full Text] [Related]